Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human papillomavirus vaccine (CNIC)
- Development stage
- Preclinical
- Lead developer
- Centro Nacional de Investigaciones Científicas
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The human papillomavirus (HPV) vaccine candidate developed by the Centro Nacional de Investigaciones Científicas (CNIC) in Cuba is a preclinical-stage prophylactic vaccine. Developed in collaboration with BioCubaFarma and the Centro Nacional de Biopreparados (BioCen), the vaccine aims to prevent HPV infection and the subsequent development of cervical cancer. The project involves the production of recombinant antigens and their formulation into a vaccine candidate intended to induce a robust immune response. As of 2023, the vaccine was undergoing scale-up and preparation for animal model testing. The specific vaccine platform and formulation details have not been publicly disclosed.
- Other names
- HPV vaccinevacuna contra el VPH
Beyond the preview
Go deeper on human papillomavirus vaccine (CNIC).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human papillomavirus vaccine (CNIC).